White House Says $14.1 Billion U.S. Steel Sale Deserves ‘Serious Scrutiny’
Under the deal, Japan’s Nippon Steel would acquire one of America’s most storied industrial enterprises.
Nike Sends Warning About Slowing Consumer Spending
Sneaker giant cuts revenue outlook and outlines cost-cutting plan to save up to $2 billion
Sumitomo Life to Buy Singapore Insurer in S$4.6 Billion Deal
Sumitomo Life Insurance has agreed to buy Singapore Life Holdings in a deal that will value the homegrown insurer at 4.6 billion Singapore dollars (US$3.47 billion).
This Retailer Launched Last Year and It’s Shipping a Million Packages a Day
Newcomer Temu and Shein are targeting bargain hunters and benefit from lower shipping costs by sorting packages in China.
Elon Musk tells Cathie Wood he wants to make X a ‘giant brain’ and financial platform
Musk spoke in a wide-ranging, 100-minute interview with Cathie Wood, chief executive of investment-management firm ARK Invest, on X’s Spaces app Thursday.
Activision and California Agency File Settlement of Gender Discrimination Claims
State withdraws claims of sexual harassment as Activision agrees to pay nearly $55 million while denying wrongdoing.
Energy Company Hess Agrees to Pay Up to $187 Million to Settle Asbestos Claims
With the deal, a bankrupt Hess subsidiary is on its way to exit chapter 11.
Warner and Paramount CEOs Discussed Possible Merger of Companies
Warner Bros. Discovery CEO David Zaslav met Paramount CEO Bob Bakish and discussed a possible merger between the media giants, people familiar with the matter said-a deal that would unite some of Hollywood and cable’s biggest brands.
U.K. Serious Fraud Office Must Pay Mining Company After Botched Corruption Probe
A court found the agency committed a ‘serious breach’ when it privately conferred with a lawyer representing ENRC.
Ultragenyx to Pay $6 Million to Settle Alleged False Medicare, Medicaid Claims
The Justice Department alleges Ultragenyx paid for free genetic tests for patients, and bought test results, to induce prescriptions of its drug Crysvita.
Source: Dow Jones Newswires